Aspen API. More than just an API.
01 1Aspen Oss B.V.
02 2DARMERICA, LLC
03 1GRINDEKS Joint Stock Company
04 1Hemmo Pharmaceuticals Pvt. Ltd
05 1Hubei JXBio Pharmaceutical Co.,Ltd
06 1Hybio Pharmaceutical Co. Ltd
07 1LETCO MEDICAL, LLC
08 1Medisca Inc
09 7Piramal Pharma Limited
10 1Professional Compounding Centers of America
11 1Qingdao Biopeptek Co., Ltd.
12 1Shanghai Soho-Yiming Pharmaceuticals Co., Ltd.
13 1Spectrum Laboratory Products Inc.
14 1Zhejiang Peptites Biotech
01 2OXYTOCIN
02 16Oxytocin
03 1Oxytocin Acetate
04 2oxytocin
01 4China
02 1Latvia
03 1Netherlands
04 14U.S.A
05 1United Kingdom
Aspen API. More than just an API.
NDC Package Code : 60870-0438
Start Marketing Date : 1999-07-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 14403-0015
Start Marketing Date : 2022-11-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-2492
Start Marketing Date : 2015-08-21
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 41701-002
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5000000[iU]/5000000[iU])
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-002
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50000000[iU]/50000000[iU])
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-002
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (10000000[iU]/10000000[iU])
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-002
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (30000000[iU]/30000000[iU])
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-017
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (5g/5g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-017
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
NDC Package Code : 41701-017
Start Marketing Date : 2011-03-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (15g/15g)
Marketing Category : BULK INGREDIENT
A Oxytocin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxytocin, including repackagers and relabelers. The FDA regulates Oxytocin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxytocin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxytocin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxytocin supplier is an individual or a company that provides Oxytocin active pharmaceutical ingredient (API) or Oxytocin finished formulations upon request. The Oxytocin suppliers may include Oxytocin API manufacturers, exporters, distributors and traders.
click here to find a list of Oxytocin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Oxytocin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Oxytocin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Oxytocin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Oxytocin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Oxytocin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Oxytocin suppliers with NDC on PharmaCompass.
We have 13 companies offering Oxytocin
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
